XLP Trademark

Trademark Overview

On Wednesday, October 30, 2019, a trademark application was filed for XLP with the United States Patent and Trademark Office. The USPTO has given the XLP trademark a serial number of 88674655. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 17, 2023. This trademark is owned by Kite Pharma, Inc.. The XLP trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacturing of biological tissue, blood, and cell cultures for medical purposes; custom manufacturing of pharmaceutical preparations for immunotherapy, including T cell therapy; custom manufacturing of biological preparations for the treatment of cancer
xlp

General Information

Serial Number88674655
Word MarkXLP
Filing DateWednesday, October 30, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 17, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2020

Trademark Statements

Goods and ServicesCustom manufacturing of biological tissue, blood, and cell cultures for medical purposes; custom manufacturing of pharmaceutical preparations for immunotherapy, including T cell therapy; custom manufacturing of biological preparations for the treatment of cancer

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, November 4, 2019
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKite Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404
Party NameKite Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Monica, CA 90404

Trademark Events

Event DateEvent Description
Monday, April 17, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 17, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 5 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 5 FILED
Monday, August 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 26, 2022SOU EXTENSION 4 GRANTED
Wednesday, January 26, 2022SOU EXTENSION 4 FILED
Wednesday, January 26, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 15, 2021SOU EXTENSION 3 GRANTED
Thursday, July 15, 2021SOU EXTENSION 3 FILED
Thursday, July 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, January 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021SOU EXTENSION 2 GRANTED
Monday, January 25, 2021SOU EXTENSION 2 FILED
Monday, January 25, 2021SOU TEAS EXTENSION RECEIVED
Thursday, August 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2020SOU EXTENSION 1 GRANTED
Tuesday, August 4, 2020SOU EXTENSION 1 FILED
Tuesday, August 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 19, 2019ASSIGNED TO LIE
Tuesday, December 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 17, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, December 17, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 17, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, December 17, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, December 12, 2019ASSIGNED TO EXAMINER
Monday, November 4, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 2, 2019NEW APPLICATION ENTERED

Related Keywords

custom manufacturing preparations cell biological including immunotherapy treatment cancer therapy